⚙

Pathophysiology

3

Retinal arteriolar vasoconstriction

Sustained systemic hypertension drives autoregulatory vasoconstriction of retinal arterioles, producing generalized and focal arteriolar narrowing (KWB grade 1).

smooth muscle cell CL:0000192

vasoconstriction GO:0042310 ↑ INCREASED

retina UBERON:0000966 arteriole UBERON:0001980

Downstream

Chronic retinal arteriolar sclerosis Sustained arteriolar vasoconstriction progresses to chronic arteriosclerotic remodeling of the arteriolar wall.

Retinal arteriolar narrowing Vasoconstriction directly manifests ophthalmoscopically as generalized and focal narrowing of retinal arterioles, the earliest (KWB grade 1) sign of hypertensive retinopathy.

Show evidence (2 references)

PMID:36418425 SUPPORT Human Clinical

"grade 1 (mild narrowing or sclerosis of retinal arterioles) and 2 (moderate to severe retinal arterioles, venous compressions at A-V"

This BIHS position document defines KWB grade 1 as mild arteriolar narrowing, the earliest vasoconstrictive change modeled by this node.

PMID:36196693 SUPPORT Human Clinical

"Hypertensive retinopathy (HR) is the most common ocular manifestation of systemic arterial hypertension."

Establishes systemic hypertension as the causal driver of the retinal arteriolar changes modeled by this node.

Chronic retinal arteriolar sclerosis

Chronic arteriosclerotic remodeling of the arteriolar wall (media hypertrophy, hyaline degeneration) produces arteriovenous nicking and an exaggerated arterial light reflex at vascular crossings (KWB grade 2).

retinal blood vessel endothelial cell CL:0002585 smooth muscle cell CL:0000192

blood vessel remodeling GO:0001974 ⚠ ABNORMAL

retina UBERON:0000966 arteriole UBERON:0001980

Downstream

Stroke Chronic hypertensive arteriolar remodeling, graded by ophthalmoscopy, independently predicts long-term stroke risk even in treated patients with well-controlled blood pressure.

Acute blood-retinal barrier breakdown in accelerated hypertension Chronic arteriolar sclerotic change predisposes to focal ischemia and barrier breakdown when blood pressure rises further or acutely decompensates.

Arteriovenous nicking Chronic arteriosclerotic remodeling of the arteriolar wall directly produces the compression of the venule at arteriovenous crossings (AV nicking) that defines KWB grade 2.

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"2 (moderate to severe retinal arterioles, venous compressions at A-V"

This BIHS position document defines KWB grade 2 as the arteriosclerotic AV-crossing changes modeled by this node.

Acute blood-retinal barrier breakdown in accelerated hypertension

In severe or rapidly rising blood pressure that exceeds retinal autoregulatory capacity, retinal vascular autoregulation fails; humoral vasoconstrictors and endothelial injury drive breakdown of the blood-retinal barrier. This produces exudation of plasma and blood into the retina (flame-shaped hemorrhages, hard exudates), microinfarction of the retinal nerve fiber layer (cotton-wool spots), and, in malignant hypertension, bilateral optic disc swelling (papilledema).

retinal blood vessel endothelial cell CL:0002585

vascular permeability GO:0043114 ↑ INCREASED

retina UBERON:0000966

Downstream

Retinal hemorrhage Breakdown of the blood-retinal barrier allows extravasation of blood into the retina, producing flame- or dot-shaped hemorrhages.

Cotton-wool spots Microinfarction of the retinal nerve fiber layer, driven by the same ischemic/endothelial injury process, produces cotton-wool spots.

Hard exudates Breakdown of the blood-retinal barrier allows exudation of lipid-rich plasma into the retina, producing hard exudates.

Papilledema In malignant hypertension, the same blood-retinal barrier breakdown process extends to the optic disc, producing bilateral papilledema (KWB grade 4).

Show evidence (2 references)

PMID:36418425 SUPPORT Human Clinical

"Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton wool spots and grade 4 i.e., optic disc swelling retinal changes essentially depict pathophysiology of severe retinal vascular permeability and are associated with poor prognosis."

Defines the KWB grade 3/4 exudative-hemorrhagic-papilledema signs modeled by this node and their diagnostic role in malignant hypertension.

PMID:36418425 SUPPORT Human Clinical

"The release of humoral vasoconstrictors leading to endothelial damage has been implicated. This vascular ischaemic state further leads to increased systemic vascular resistance, leading to pressure natriuresis which results in further activation of RAAS."

Supports the humoral-vasoconstrictor/endothelial-injury mechanism of barrier breakdown in accelerated/malignant hypertension.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

7

Cardiovascular 1

Stroke HP:0001297

Show evidence (1 reference)

PMID:23940194 SUPPORT Human Clinical

"moderate versus no retinopathy: multivariable hazard ratios, 2.37 [95% confidence interval, 1.39-4.02]"

In a 2907-participant ARIC cohort followed 13 years, moderate hypertensive retinopathy independently predicted incident stroke after adjusting for age, sex, blood pressure, and other risk factors.

Eye 2

Cotton-wool spots Retinal cotton wool spot HP:0031606

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton wool spots"

Defines grade 3 KWB cotton-wool spots.

Papilledema HP:0001085

Some modern clinicopathologic frameworks separate fundus findings into hypertensive retinopathy, choroidopathy, and optic neuropathy, and reclassify optic disc edema as hypertensive optic neuropathy rather than retinopathy proper; it is retained here as KWB grade 4 per the still-dominant Keith-Wagener-Barker clinical classification used by the cited evidence.

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"grade 4 i.e., optic disc swelling retinal changes"

Defines grade 4 KWB bilateral papilledema and its role in the clinical diagnosis of malignant hypertension.

Other 4

Retinal arteriolar narrowing Attenuation of retinal blood vessels HP:0007843

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"grade 1 (mild narrowing or sclerosis of retinal arterioles)"

Defines grade 1 KWB retinal arteriolar narrowing/sclerosis.

Arteriovenous nicking Arteriovenous crossing sign HP:6001216

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"2 (moderate to severe retinal arterioles, venous compressions at A-V"

Defines grade 2 KWB AV nicking / exaggerated light reflex.

Retinal hemorrhage HP:0000573

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton wool spots"

Defines grade 3 KWB flame/dot-shaped retinal hemorrhage.

Hard exudates Retinal exudate HP:0001147

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton wool spots"

Defines grade 3 KWB hard exudates.

💊

Medical Actions

1

Systemic blood pressure control

Action: Pharmacotherapy NCIT:C15986

Agent: amlodipine CHEBI:2668 atenolol CHEBI:2904

Management is directed at controlling the underlying systemic hypertension rather than treating the retina directly; in uncomplicated malignant hypertension (grade 3-4 retinopathy with eye changes only), blood pressure should be lowered gradually over days to weeks rather than hours, to avoid ischemic complications from disrupted retinal/cerebral autoregulation.

Mechanism Target:

MODULATES Retinal arteriolar vasoconstriction — Blood pressure control reduces the vasoconstrictive stimulus on retinal arterioles and can reverse early-stage changes.

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"Eye changes usually regress with treatment, rarely without treatment."

Supports blood pressure control as reversing retinal arteriolar changes.

MODULATES Chronic retinal arteriolar sclerosis — Blood pressure control reduces the sclerotic stimulus on retinal arterioles and can partially reverse early-stage changes.

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"Eye changes usually regress with treatment, rarely without treatment."

Supports blood pressure control as reversing retinal arteriolar changes.

Show evidence (2 references)

PMID:36418425 SUPPORT Human Clinical

"In uncomplicated MHT (eye changes alone) BP is to be lowered within days, aiming for gradual reduction to reach target BP within weeks. For example: within 24 h lower to <200/120 mmHg, within a week <160/100 mmHg, then to <140/90 mmHg within 6-12 weeks."

Defines the graduated blood-pressure-lowering targets for malignant hypertension presenting with eye changes (grade 3-4 retinopathy) alone.

PMID:36418425 SUPPORT Human Clinical

"Oral medications calcium channel blockers (CCB) such as amlodipine 5 mg or long acting nifedipine"

First-line oral pharmacotherapy for malignant hypertension with eye changes alone.

🌍

Environmental Factors

1

Systemic arterial hypertension

Chronic or acute severe systemic hypertension is the causal exposure for hypertensive retinopathy.

Show evidence (1 reference)

PMID:36196693 SUPPORT Human Clinical

"Hypertensive retinopathy (HR) is the most common ocular manifestation of systemic arterial hypertension."

Establishes systemic hypertension as the causal exposure.

🔬

Diagnosis

2

Dilated fundus examination with KWB grading

Ophthalmoscopic examination of the retina, graded by the Keith-Wagener-Barker (or modified Scheie) system, is the standard diagnostic method, though it is limited by interobserver variability.

dilated fundus examination NCIT:C38060

Results: KWB grade 1-4 based on arteriolar narrowing, AV nicking, hemorrhages/exudates, and papilledema.

Show evidence (1 reference)

PMID:36196693 SUPPORT Human Clinical

"HR is even now diagnosed and classified by its clinical appearance on a fundoscopic exam that is limited by interobserver variability."

Supports fundoscopic KWB grading as the standard, though subjective, diagnostic method.

OCT angiography quantitative retinal microvascular assessment

Optical coherence tomography angiography (OCTA) can detect reduced retinal microvascular density in hypertension-associated states before or alongside overt fundoscopic hypertensive retinopathy, complementing classic KWB grading with a quantitative, non-invasive measure.

optical coherence tomography NCIT:C20828

Results: Superficial and deep macular retinal vascular density (superficial/deep vascular plexus).

Show evidence (2 references)

PMID:39572632 SUPPORT Human Clinical

"in SVP, the density of TMI, MIR, and MAR in the RH group was significantly lower compared to the HCs group"

Demonstrates OCTA-detectable reduction in retinal microvascular density in a renal-hypertension cohort versus healthy controls.

PMID:35683999 SUPPORT Human Clinical

"retinal microcirculation offers the unique advantage of being directly accessible to non-invasive and relatively simple investigation tools"

Supports the rationale for retinal imaging (OCT/OCTA) as a non-invasive window onto hypertension-mediated vascular change.

📊

Prevalence

2

Malignant hypertension (bilateral grade 3-4 hypertensive retinopathy), Caucasian population

Point Prevalence 1.0–2.0 per 100,000 1–9 per 100,000

BIHS position document epidemiology table; malignant hypertension is clinically defined by concurrent bilateral grade 3 or 4 hypertensive retinopathy, so this figure is a lower-bound proxy for severe/malignant-grade retinopathy rather than overall hypertensive retinopathy prevalence (which is not separately quantified in the cited evidence).

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"1– 2/100,000 in Caucasian population"

Malignant hypertension prevalence, defined by bilateral grade 3/4 hypertensive retinopathy.

Malignant hypertension (bilateral grade 3-4 hypertensive retinopathy), African American population

Point Prevalence 7.3 per 100,000 1–9 per 100,000

Same BIHS epidemiology table; reported ethnicity-stratified malignant hypertension prevalence.

Show evidence (1 reference)

PMID:36418425 SUPPORT Human Clinical

"7.3/100,000 in African American population"

Malignant hypertension prevalence in an African American population, defined by bilateral grade 3/4 hypertensive retinopathy.

{ }

Source YAML

click to show

name: Hypertensive Retinopathy
creation_date: "2026-07-14T00:00:00Z"
description: >-
  Hypertensive retinopathy is a chronic and acute retinal vascular disorder
  caused by systemic arterial hypertension. Sustained or severe blood pressure
  elevation produces a spectrum of retinal vascular changes, classically
  graded with the Keith-Wagener-Barker (KWB) system: early arteriolar
  vasoconstriction and narrowing, progressing to arteriosclerotic changes
  (arteriovenous nicking, copper/silver wiring), and in accelerated/malignant
  hypertension, breakdown of the blood-retinal barrier producing flame-shaped
  hemorrhages, cotton-wool spots, hard exudates, and bilateral papilledema
  (grade 4, the defining ophthalmoscopic feature of malignant hypertension).
category: Complex
disease_term:
  preferred_term: hypertensive retinopathy
  term:
    id: MONDO:0006797
    label: hypertensive retinopathy
synonyms:
- retinopathy due to hypertension
- hypertensive retinal vasculopathy
parents:
- Retinal vascular disorder
pathophysiology:
- name: Retinal arteriolar vasoconstriction
  description: >-
    Sustained systemic hypertension drives autoregulatory vasoconstriction of
    retinal arterioles, producing generalized and focal arteriolar narrowing
    (KWB grade 1).
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  - preferred_term: arteriole
    term:
      id: UBERON:0001980
      label: arteriole
  cell_types:
  - preferred_term: smooth muscle cell
    term:
      id: CL:0000192
      label: smooth muscle cell
  biological_processes:
  - preferred_term: vasoconstriction
    modifier: INCREASED
    term:
      id: GO:0042310
      label: vasoconstriction
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      grade 1 (mild narrowing or sclerosis of retinal arterioles) and 2
      (moderate to severe retinal arterioles, venous compressions at A-V
    explanation: >-
      This BIHS position document defines KWB grade 1 as mild arteriolar
      narrowing, the earliest vasoconstrictive change modeled by this node.
  - reference: PMID:36196693
    reference_title: "A literature review of hypertensive retinopathy: systemic correlations and new technologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypertensive retinopathy (HR) is the most common ocular manifestation
      of systemic arterial hypertension.
    explanation: >-
      Establishes systemic hypertension as the causal driver of the retinal
      arteriolar changes modeled by this node.
  downstream:
  - target: Chronic retinal arteriolar sclerosis
    description: >-
      Sustained arteriolar vasoconstriction progresses to chronic
      arteriosclerotic remodeling of the arteriolar wall.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        grade 1 (mild narrowing or sclerosis of retinal arterioles) and 2
        (moderate to severe retinal arterioles, venous compressions at A-V
      explanation: >-
        KWB grades 1 and 2 are both chronic arteriolar changes of
        progressive severity, with grade 1 (narrowing) preceding grade 2
        (sclerotic AV-crossing changes).
  - target: Retinal arteriolar narrowing
    description: >-
      Vasoconstriction directly manifests ophthalmoscopically as generalized
      and focal narrowing of retinal arterioles, the earliest (KWB grade 1)
      sign of hypertensive retinopathy.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        grade 1 (mild narrowing or sclerosis of retinal arterioles)
      explanation: Defines grade 1 KWB retinal arteriolar narrowing as the ophthalmoscopic sign of this node's vasoconstriction.
- name: Chronic retinal arteriolar sclerosis
  description: >-
    Chronic arteriosclerotic remodeling of the arteriolar wall (media
    hypertrophy, hyaline degeneration) produces arteriovenous nicking and an
    exaggerated arterial light reflex at vascular crossings (KWB grade 2).
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  - preferred_term: arteriole
    term:
      id: UBERON:0001980
      label: arteriole
  cell_types:
  - preferred_term: retinal blood vessel endothelial cell
    term:
      id: CL:0002585
      label: retinal blood vessel endothelial cell
  - preferred_term: smooth muscle cell
    term:
      id: CL:0000192
      label: smooth muscle cell
  biological_processes:
  - preferred_term: blood vessel remodeling
    modifier: ABNORMAL
    term:
      id: GO:0001974
      label: blood vessel remodeling
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      2 (moderate to severe retinal arterioles, venous compressions at A-V
    explanation: >-
      This BIHS position document defines KWB grade 2 as the arteriosclerotic
      AV-crossing changes modeled by this node.
  downstream:
  - target: Stroke
    description: >-
      Chronic hypertensive arteriolar remodeling, graded by ophthalmoscopy,
      independently predicts long-term stroke risk even in treated patients
      with well-controlled blood pressure.
    evidence:
    - reference: PMID:23940194
      reference_title: Hypertensive retinopathy and risk of stroke.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        moderate versus no retinopathy: multivariable hazard ratios, 2.37
        [95% confidence interval, 1.39-4.02]
      explanation: >-
        In a 2907-participant ARIC cohort followed 13 years, moderate
        hypertensive retinopathy independently predicted incident stroke
        after adjusting for age, sex, blood pressure, and other risk
        factors.
  - target: Acute blood-retinal barrier breakdown in accelerated hypertension
    description: >-
      Chronic arteriolar sclerotic change predisposes to focal ischemia and
      barrier breakdown when blood pressure rises further or acutely
      decompensates.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Practically, detection of grades 1 and 2 can be used to
      explanation: >-
        Supports grades 1-2 (chronic arteriolar change) as the baseline
        state from which the accelerated grade 3-4 phenotype develops.
  - target: Arteriovenous nicking
    description: >-
      Chronic arteriosclerotic remodeling of the arteriolar wall directly
      produces the compression of the venule at arteriovenous crossings
      (AV nicking) that defines KWB grade 2.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        2 (moderate to severe retinal arterioles, venous compressions at A-V
      explanation: Defines grade 2 KWB AV nicking as the ophthalmoscopic sign of this node's arteriolar sclerosis.
- name: Acute blood-retinal barrier breakdown in accelerated hypertension
  description: >-
    In severe or rapidly rising blood pressure that exceeds retinal
    autoregulatory capacity, retinal vascular autoregulation fails; humoral
    vasoconstrictors and endothelial injury drive breakdown of the
    blood-retinal barrier. This produces exudation of plasma and blood into
    the retina (flame-shaped hemorrhages, hard exudates), microinfarction of
    the retinal nerve fiber layer (cotton-wool spots), and, in malignant
    hypertension, bilateral optic disc swelling (papilledema).
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  cell_types:
  - preferred_term: retinal blood vessel endothelial cell
    term:
      id: CL:0002585
      label: retinal blood vessel endothelial cell
  biological_processes:
  - preferred_term: vascular permeability
    modifier: INCREASED
    term:
      id: GO:0043114
      label: regulation of vascular permeability
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
      wool spots and grade 4 i.e., optic disc swelling retinal changes
      essentially depict pathophysiology of severe retinal vascular
      permeability and are associated with poor prognosis.
    explanation: >-
      Defines the KWB grade 3/4 exudative-hemorrhagic-papilledema signs
      modeled by this node and their diagnostic role in malignant
      hypertension.
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The release of humoral vasoconstrictors leading to endothelial damage
      has been implicated. This vascular ischaemic state further leads to
      increased systemic vascular resistance, leading to pressure
      natriuresis which results in further activation of RAAS.
    explanation: >-
      Supports the humoral-vasoconstrictor/endothelial-injury mechanism of
      barrier breakdown in accelerated/malignant hypertension.
  downstream:
  - target: Retinal hemorrhage
    description: >-
      Breakdown of the blood-retinal barrier allows extravasation of blood
      into the retina, producing flame- or dot-shaped hemorrhages.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
        wool spots
      explanation: Defines grade 3 KWB retinal hemorrhage as a direct sign of this node's barrier breakdown.
  - target: Cotton-wool spots
    description: >-
      Microinfarction of the retinal nerve fiber layer, driven by the same
      ischemic/endothelial injury process, produces cotton-wool spots.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
        wool spots
      explanation: Defines grade 3 KWB cotton-wool spots as a direct sign of this node's barrier breakdown.
  - target: Hard exudates
    description: >-
      Breakdown of the blood-retinal barrier allows exudation of
      lipid-rich plasma into the retina, producing hard exudates.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
        wool spots
      explanation: Defines grade 3 KWB hard exudates as a direct sign of this node's barrier breakdown.
  - target: Papilledema
    description: >-
      In malignant hypertension, the same blood-retinal barrier breakdown
      process extends to the optic disc, producing bilateral papilledema
      (KWB grade 4).
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        grade 4 i.e., optic disc swelling retinal changes
      explanation: Defines grade 4 KWB bilateral papilledema as a direct sign of this node's barrier breakdown.
phenotypes:
- category: Ophthalmologic
  name: Retinal arteriolar narrowing
  description: >-
    Generalized and focal narrowing of retinal arterioles is the earliest
    (KWB grade 1) ophthalmoscopic sign of hypertensive retinopathy.
  phenotype_term:
    preferred_term: Attenuation of retinal blood vessels
    term:
      id: HP:0007843
      label: Attenuation of retinal blood vessels
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      grade 1 (mild narrowing or sclerosis of retinal arterioles)
    explanation: Defines grade 1 KWB retinal arteriolar narrowing/sclerosis.
- category: Ophthalmologic
  name: Arteriovenous nicking
  description: >-
    Compression of the venule at arteriovenous crossings (AV nicking), with
    an exaggerated arterial light reflex, is a KWB grade 2 sign of chronic
    arteriosclerotic change.
  phenotype_term:
    preferred_term: Arteriovenous nicking
    term:
      id: HP:6001216
      label: Arteriovenous crossing sign
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      2 (moderate to severe retinal arterioles, venous compressions at A-V
    explanation: Defines grade 2 KWB AV nicking / exaggerated light reflex.
- category: Ophthalmologic
  name: Retinal hemorrhage
  description: >-
    Flame- or dot-shaped retinal hemorrhages are a KWB grade 3 sign
    reflecting blood-retinal barrier breakdown in accelerated hypertension.
  phenotype_term:
    preferred_term: Retinal hemorrhage
    term:
      id: HP:0000573
      label: Retinal hemorrhage
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
      wool spots
    explanation: Defines grade 3 KWB flame/dot-shaped retinal hemorrhage.
- category: Ophthalmologic
  name: Cotton-wool spots
  description: >-
    Cotton-wool spots represent microinfarcts of the retinal nerve fiber
    layer from ischemia in accelerated hypertensive retinopathy (KWB grade 3).
  phenotype_term:
    preferred_term: Cotton-wool spots
    term:
      id: HP:0031606
      label: Retinal cotton wool spot
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
      wool spots
    explanation: Defines grade 3 KWB cotton-wool spots.
- category: Ophthalmologic
  name: Hard exudates
  description: >-
    Lipid-rich hard exudates result from chronic plasma leakage and are a
    KWB grade 3 sign; they can form a macular star pattern in severe
    hypertensive retinopathy.
  phenotype_term:
    preferred_term: Hard exudates
    term:
      id: HP:0001147
      label: Retinal exudate
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bilateral grade 3 i.e., retinal haemorrhage, hard exudates, cotton
      wool spots
    explanation: Defines grade 3 KWB hard exudates.
- category: Ophthalmologic
  name: Papilledema
  description: >-
    Bilateral optic disc swelling (papilledema) defines KWB grade 4,
    malignant hypertensive retinopathy, and reflects severe vascular
    permeability with poor prognosis if untreated.
  phenotype_term:
    preferred_term: Papilledema
    term:
      id: HP:0001085
      label: Papilledema
  notes: >-
    Some modern clinicopathologic frameworks separate fundus findings into
    hypertensive retinopathy, choroidopathy, and optic neuropathy, and
    reclassify optic disc edema as hypertensive optic neuropathy rather
    than retinopathy proper; it is retained here as KWB grade 4 per the
    still-dominant Keith-Wagener-Barker clinical classification used by
    the cited evidence.
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      grade 4 i.e., optic disc swelling retinal changes
    explanation: Defines grade 4 KWB bilateral papilledema and its role in the clinical diagnosis of malignant hypertension.
- category: Neurologic
  name: Stroke
  description: >-
    Chronic hypertensive retinal arteriolar remodeling (KWB grade 2),
    reflecting systemic small-vessel injury, independently predicts
    incident stroke, even in patients treated for hypertension.
  phenotype_term:
    preferred_term: Stroke
    term:
      id: HP:0001297
      label: Stroke
  evidence:
  - reference: PMID:23940194
    reference_title: Hypertensive retinopathy and risk of stroke.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      moderate versus no retinopathy: multivariable hazard ratios, 2.37
      [95% confidence interval, 1.39-4.02]
    explanation: >-
      In a 2907-participant ARIC cohort followed 13 years, moderate
      hypertensive retinopathy independently predicted incident stroke
      after adjusting for age, sex, blood pressure, and other risk
      factors.
environmental:
- name: Systemic arterial hypertension
  presence: Positive
  description: >-
    Chronic or acute severe systemic hypertension is the causal exposure for
    hypertensive retinopathy.
  evidence:
  - reference: PMID:36196693
    reference_title: "A literature review of hypertensive retinopathy: systemic correlations and new technologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypertensive retinopathy (HR) is the most common ocular manifestation
      of systemic arterial hypertension.
    explanation: Establishes systemic hypertension as the causal exposure.
prevalence:
- population: Malignant hypertension (bilateral grade 3-4 hypertensive retinopathy), Caucasian population
  measure_type: POINT_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_low: 1.0
  rate_high: 2.0
  notes: >-
    BIHS position document epidemiology table; malignant hypertension is
    clinically defined by concurrent bilateral grade 3 or 4 hypertensive
    retinopathy, so this figure is a lower-bound proxy for
    severe/malignant-grade retinopathy rather than overall hypertensive
    retinopathy prevalence (which is not separately quantified in the
    cited evidence).
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "1– 2/100,000 in Caucasian population"
    explanation: Malignant hypertension prevalence, defined by bilateral grade 3/4 hypertensive retinopathy.
- population: Malignant hypertension (bilateral grade 3-4 hypertensive retinopathy), African American population
  measure_type: POINT_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 7.3
  notes: >-
    Same BIHS epidemiology table; reported ethnicity-stratified malignant
    hypertension prevalence.
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "7.3/100,000 in African American population"
    explanation: Malignant hypertension prevalence in an African American population, defined by bilateral grade 3/4 hypertensive retinopathy.
diagnosis:
- name: Dilated fundus examination with KWB grading
  description: >-
    Ophthalmoscopic examination of the retina, graded by the
    Keith-Wagener-Barker (or modified Scheie) system, is the standard
    diagnostic method, though it is limited by interobserver variability.
  diagnosis_term:
    preferred_term: dilated fundus examination
    term:
      id: NCIT:C38060
      label: Eye Examination
  results: KWB grade 1-4 based on arteriolar narrowing, AV nicking, hemorrhages/exudates, and papilledema.
  evidence:
  - reference: PMID:36196693
    reference_title: "A literature review of hypertensive retinopathy: systemic correlations and new technologies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      HR is even now diagnosed and classified by its clinical appearance on
      a fundoscopic exam that is limited by interobserver variability.
    explanation: Supports fundoscopic KWB grading as the standard, though subjective, diagnostic method.
- name: OCT angiography quantitative retinal microvascular assessment
  description: >-
    Optical coherence tomography angiography (OCTA) can detect reduced
    retinal microvascular density in hypertension-associated states before
    or alongside overt fundoscopic hypertensive retinopathy, complementing
    classic KWB grading with a quantitative, non-invasive measure.
  diagnosis_term:
    preferred_term: optical coherence tomography
    term:
      id: NCIT:C20828
      label: Optical Coherence Tomography
  results: Superficial and deep macular retinal vascular density (superficial/deep vascular plexus).
  evidence:
  - reference: PMID:39572632
    reference_title: OCTA evaluates changes in retinal microvasculature in renal hypertension patients.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      in SVP, the density of TMI, MIR, and MAR in the RH group was
      significantly lower compared to the HCs group
    explanation: >-
      Demonstrates OCTA-detectable reduction in retinal microvascular
      density in a renal-hypertension cohort versus healthy controls.
  - reference: PMID:35683999
    reference_title: "Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      retinal microcirculation offers the unique advantage of being
      directly accessible to non-invasive and relatively simple
      investigation tools
    explanation: >-
      Supports the rationale for retinal imaging (OCT/OCTA) as a
      non-invasive window onto hypertension-mediated vascular change.
treatments:
- name: Systemic blood pressure control
  description: >-
    Management is directed at controlling the underlying systemic
    hypertension rather than treating the retina directly; in uncomplicated
    malignant hypertension (grade 3-4 retinopathy with eye changes only),
    blood pressure should be lowered gradually over days to weeks rather than
    hours, to avoid ischemic complications from disrupted retinal/cerebral
    autoregulation.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: amlodipine
      term:
        id: CHEBI:2668
        label: amlodipine
    - preferred_term: atenolol
      term:
        id: CHEBI:2904
        label: atenolol
  target_mechanisms:
  - target: Retinal arteriolar vasoconstriction
    treatment_effect: MODULATES
    description: >-
      Blood pressure control reduces the vasoconstrictive stimulus on
      retinal arterioles and can reverse early-stage changes.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Eye changes usually regress with treatment, rarely without treatment."
      explanation: Supports blood pressure control as reversing retinal arteriolar changes.
  - target: Chronic retinal arteriolar sclerosis
    treatment_effect: MODULATES
    description: >-
      Blood pressure control reduces the sclerotic stimulus on retinal
      arterioles and can partially reverse early-stage changes.
    evidence:
    - reference: PMID:36418425
      reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: "Eye changes usually regress with treatment, rarely without treatment."
      explanation: Supports blood pressure control as reversing retinal arteriolar changes.
  evidence:
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In uncomplicated MHT (eye changes alone) BP is to be lowered within
      days, aiming for gradual reduction to reach target BP within weeks.
      For example: within 24 h lower to <200/120 mmHg, within a week
      <160/100 mmHg, then to <140/90 mmHg within 6-12 weeks.
    explanation: >-
      Defines the graduated blood-pressure-lowering targets for malignant
      hypertension presenting with eye changes (grade 3-4 retinopathy) alone.
  - reference: PMID:36418425
    reference_title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Oral medications calcium channel blockers (CCB) such as amlodipine
      5 mg or long acting nifedipine
    explanation: First-line oral pharmacotherapy for malignant hypertension with eye changes alone.
datasets: []
animal_models: []
references:
- reference: PMID:36196693
  title: "A literature review of hypertensive retinopathy: systemic correlations and new technologies."
  found_in:
  - Hypertensive_Retinopathy-deep-research-falcon.md
  findings:
  - statement: Hypertensive retinopathy is the most common ocular manifestation of systemic arterial hypertension, diagnosed by subjective fundoscopic grading.
    supporting_text: >-
      Hypertensive retinopathy (HR) is the most common ocular manifestation
      of systemic arterial hypertension.
- reference: PMID:36418425
  title: "Management of hypertensive crisis: British and Irish Hypertension Society Position document."
  found_in:
  - Hypertensive_Retinopathy-deep-research-falcon.md
  findings:
  - statement: Malignant hypertension is clinically defined by concurrent bilateral grade 3 or grade 4 Keith-Wagener-Barker hypertensive retinopathy.
    supporting_text: >-
      the clinical diagnosis requires concurrent bilateral grade 3 (flame
      or dot-shaped haemorrhages, cotton-wool spots, hard exudates and
      microaneurysms) or grade 4 hypertensive retinopathy (bilateral
      papilloedema)
- reference: PMID:23940194
  title: Hypertensive retinopathy and risk of stroke.
  findings:
  - statement: Moderate hypertensive retinopathy independently predicts incident stroke over 13-year follow-up in the ARIC cohort.
    supporting_text: >-
      moderate versus no retinopathy: multivariable hazard ratios, 2.37
      [95% confidence interval, 1.39-4.02]
- reference: PMID:39572632
  title: OCTA evaluates changes in retinal microvasculature in renal hypertension patients.
  found_in:
  - Hypertensive_Retinopathy-deep-research-falcon.md
  findings:
  - statement: OCTA detects significantly reduced macular retinal vascular density in renal hypertension patients versus healthy controls.
    supporting_text: >-
      in SVP, the density of TMI, MIR, and MAR in the RH group was
      significantly lower compared to the HCs group
- reference: PMID:35683999
  title: "Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies."
  found_in:
  - Hypertensive_Retinopathy-deep-research-falcon.md
  findings:
  - statement: Retinal microcirculation is a directly accessible, non-invasive window for assessing hypertension-mediated organ damage.
    supporting_text: >-
      retinal microcirculation offers the unique advantage of being
      directly accessible to non-invasive and relatively simple
      investigation tools

📚

References & Deep Research

References

5

PMID:36196693

A literature review of hypertensive retinopathy: systemic correlations and new technologies.

1 finding

Hypertensive retinopathy is the most common ocular manifestation of systemic arterial hypertension, diagnosed by subjective fundoscopic grading.

"Hypertensive retinopathy (HR) is the most common ocular manifestation of systemic arterial hypertension."

PMID:36418425

Management of hypertensive crisis: British and Irish Hypertension Society Position document.

1 finding

Malignant hypertension is clinically defined by concurrent bilateral grade 3 or grade 4 Keith-Wagener-Barker hypertensive retinopathy.

"the clinical diagnosis requires concurrent bilateral grade 3 (flame or dot-shaped haemorrhages, cotton-wool spots, hard exudates and microaneurysms) or grade 4 hypertensive retinopathy (bilateral papilloedema)"

PMID:23940194

Hypertensive retinopathy and risk of stroke.

1 finding

Moderate hypertensive retinopathy independently predicts incident stroke over 13-year follow-up in the ARIC cohort.

"moderate versus no retinopathy: multivariable hazard ratios, 2.37 [95% confidence interval, 1.39-4.02]"

PMID:39572632

OCTA evaluates changes in retinal microvasculature in renal hypertension patients.

1 finding

OCTA detects significantly reduced macular retinal vascular density in renal hypertension patients versus healthy controls.

"in SVP, the density of TMI, MIR, and MAR in the RH group was significantly lower compared to the HCs group"

PMID:35683999

Arterial Hypertension and the Hidden Disease of the Eye: Diagnostic Tools and Therapeutic Strategies.

1 finding

Retinal microcirculation is a directly accessible, non-invasive window for assessing hypertension-mediated organ damage.

"retinal microcirculation offers the unique advantage of being directly accessible to non-invasive and relatively simple investigation tools"

Deep Research

1

Falcon ▸

Recent Developments and Real-World Implementations (2023–2024 emphasis)

Edison Scientific Literature 39 citations 2026-07-14T16:12:02.934383

1. Disease Information

1.1 Concise overview (current understanding)

Hypertensive retinopathy (HR) is commonly defined as retinal microvascular signs that develop in response to raised blood pressure, representing ocular end-organ involvement of hypertension. A widely used clinical framework is the Keith–Wagener–Barker (KWB) grading system, where severe grades reflect accelerated/malignant hypertensive states and worse prognosis. (marco2022aliteraturereview pages 2-4, kulkarni2023managementofhypertensive pages 2-3)

A key pathogenetic clarification—particularly relevant in malignant hypertension—is that fundus lesions can be separated into (1) hypertensive retinopathy, (2) hypertensive choroidopathy, and (3) hypertensive optic neuropathy; notably, optic disc edema, historically included within hypertensive retinopathy, is better considered hypertensive optic neuropathy. (kim2023hypertensiveretinopathy pages 1-2)

1.2 Key identifiers (ontology/terminology)

ICD-10/ICD-11, MeSH, MONDO, OMIM, Orphanet: These identifiers were not present in the retrieved full-text evidence in this run; therefore they cannot be asserted here with primary citations.
Clinical grading systems used in current practice/literature: Keith–Wagener–Barker (KWB) grades 1–4; other grading systems (Scheie; Wong–Mitchell) are referenced in synthesis literature. (marco2022aliteraturereview pages 4-6)

1.3 Synonyms and alternative names

Historical terminology includes “albuminuric retinitis,” “angiospastic retinopathy,” and “hypertensive neuroretinopathy,” reflecting early descriptions linking severe hypertension and renal disease. (kim2023hypertensiveretinopathy pages 1-2)

1.4 Evidence source type

Evidence is primarily from aggregated disease-level resources (cohorts, systematic reviews, imaging studies, clinical guidance). The retinopathy/choroidopathy/optic-neuropathy separation is grounded in pathogenetic clinical research and clinicopathologic interpretation. (kim2023hypertensiveretinopathy pages 1-2, marco2022aliteraturereview pages 2-4)

2. Etiology

2.1 Causal factors

Primary causal driver: systemic arterial hypertension (sustained or acutely severe) producing retinal microvascular autoregulatory stress, endothelial injury, and (in severe states) blood–retina barrier disruption. (marco2022aliteraturereview pages 2-4, kim2023hypertensiveretinopathy pages 2-3)

Secondary/mediating mechanisms emphasized in recent mechanistic/imaging work: * Autoregulation failure when BP rises beyond autoregulatory thresholds, associated with endothelial injury and vascular permeability changes. (kim2023hypertensiveretinopathy pages 2-3) * Renin–angiotensin–aldosterone system (RAAS) activation and excess angiotensin II (particularly in renal/secondary hypertension) driving vasoconstriction/vasospasm, arterial stiffness, reduced retinal perfusion, and reduced OCTA-measured vascular density. (wang2024octaevaluateschanges pages 6-7, wang2024octaevaluateschanges pages 9-10)

2.2 Risk factors (representative)

Degree and duration of hypertension (epidemiology difficult to quantify precisely due to confounding retinal vascular diseases, but incidence rises with severity and duration). (marco2022aliteraturereview pages 1-2)
Chronic kidney disease / renal hypertension as a systemic context with high burden of hypertensive retinal microvascular abnormalities and reduced OCTA vessel density. (wang2024octaevaluateschanges pages 9-10)
Ethnicity/sex effect modification: BIHS position paper notes that while hypertension/retinopathy are overall more prevalent in Afro-Caribbeans than Europeans, the relationship between hypertension and retinopathy prevalence is stronger in Europeans (particularly women) and weaker in Afro-Caribbeans (especially women). (kulkarni2023managementofhypertensive pages 2-3)

2.3 Protective factors

No evidence for specific genetic or environmental protective factors was identified in the retrieved set.

2.4 Gene–environment interactions

No hypertensive-retinopathy-specific gene–environment interaction evidence was identified.

3. Phenotypes

3.1 Classic fundus signs

A synthesis review describes classic HR signs: generalized or focal arteriolar narrowing, arteriovenous (AV) nicking, copper/silver wiring, flame-shaped and dot-blot hemorrhages, hard exudates, cotton-wool spots, and microaneurysms; malignant disease may include papilledema, congested veins, and macular star. (marco2022aliteraturereview pages 2-4, marco2022aliteraturereview pages 4-6)

KWB grading (explicit features from 2023 BIHS): * Grade 1: mild narrowing/sclerosis of retinal arterioles * Grade 2: moderate–severe arteriolar changes + venous compression at AV crossings + exaggerated arterial light reflex * Grade 3: flame/dot hemorrhages, cotton-wool spots, hard exudates, microaneurysms * Grade 4: bilateral papilloedema (optic disc swelling) (kulkarni2023managementofhypertensive pages 2-3)

3.2 Retinal layers/structural phenotypes (OCT/OCTA era)

Cotton-wool spots correspond to ischemic lesions with RNFL involvement, and structural sequelae may persist with RNFL thinning and inner retinal layer changes (e.g., ganglion cell-inner plexiform layer complex). (marco2022aliteraturereview pages 6-7)

3.3 Distinguishing related entities (malignant hypertension)

Fundus lesions in malignant hypertension can be separated into hypertensive retinopathy vs choroidopathy vs optic neuropathy; optic disc edema maps to optic neuropathy rather than retinopathy. (kim2023hypertensiveretinopathy pages 1-2, marco2022aliteraturereview pages 4-6)

Suggested HPO term mappings (ontology suggestions; not evidence-asserted)

Retinal hemorrhage; cotton-wool spots (retinal nerve fiber layer infarcts); hard exudates; papilledema; macular edema; abnormal retinal vasculature/arteriolar narrowing/AV nicking.

4. Genetic/Molecular Information

4.1 Causal genes and pathogenic variants

HR is best characterized as a complex phenotype/end-organ manifestation of systemic hypertension rather than a monogenic disorder; no HR-specific causal genes or pathogenic variants were identified in the retrieved evidence.

4.2 Molecular mediators and pathways

Key mediators include endothelial dysfunction and barrier breakdown in severe states (kim2023hypertensiveretinopathy pages 2-3), and RAAS/angiotensin II-associated vasoconstriction/vasospasm with downstream vascular dysfunction in renal hypertension (wang2024octaevaluateschanges pages 6-7, wang2024octaevaluateschanges pages 9-10). A synthesis review also highlights angiotensin II–VEGF connections in HR pathophysiology. (marco2022aliteraturereview pages 2-4)

No omics (transcriptomic/proteomic/metabolomic/epigenomic) profiling evidence was identified.

5. Environmental Information

HR is driven primarily by systemic BP exposure and systemic vascular risk context. No toxin/pathogen causal triggers were identified in this run.

6. Mechanism / Pathophysiology (causal chain)

A useful mechanistic framework (synthesis review) divides HR into phases:

Vasoconstrictive phase (acute BP elevation): autoregulatory vasoconstriction/vasospasm → generalized/focal retinal arteriolar narrowing. (marco2022aliteraturereview pages 2-4)
Sclerotic phase (chronic hypertension): endothelial injury, intimal thickening, medial hyperplasia, hyaline degeneration → AV nicking and copper/silver wiring. (marco2022aliteraturereview pages 2-4)
Exudative phase (severe/accelerated hypertension): blood–retina barrier disruption and permeability → hemorrhages, hard exudates, cotton-wool spots, microaneurysms. (marco2022aliteraturereview pages 2-4)

In renal hypertension, RAAS activation and angiotensin II excess are emphasized as drivers of vasoconstriction/vasospasm and reduced retinal perfusion/vascular density on OCTA. (wang2024octaevaluateschanges pages 6-7, wang2024octaevaluateschanges pages 9-10)

Suggested GO/CL terms (ontology suggestions): endothelial cell dysfunction; regulation of blood vessel diameter; regulation of vascular permeability; oxidative stress response; retinal ganglion cell injury; pericyte/endothelial involvement.

7. Anatomical Structures Affected

Retina and retinal microvasculature (arterioles/capillaries/venules) with inner retinal layer effects (RNFL, ganglion cell complex). (marco2022aliteraturereview pages 2-4, marco2022aliteraturereview pages 6-7)
Choroid/RPE in hypertensive choroidopathy (choroidal ischemia/RPE lesions). (marco2022aliteraturereview pages 4-6, kim2023hypertensiveretinopathy pages 2-3)
Optic nerve head in hypertensive optic neuropathy (disc hemorrhage/papilledema). (marco2022aliteraturereview pages 4-6, kim2023hypertensiveretinopathy pages 1-2)

8. Temporal Development

Chronic course with remodeling signs (arteriolar narrowing, AV nicking, wiring) vs acute/severe presentations with exudative lesions and disc edema. (marco2022aliteraturereview pages 2-4, kulkarni2023managementofhypertensive pages 2-3)
Staging via KWB grades 1–4. (kulkarni2023managementofhypertensive pages 2-3)
OCTA-based 3-stage capillary sparsity/nonperfusion patterns proposed as staging surrogates in synthesis literature. (marco2022aliteraturereview pages 6-7)

9. Inheritance and Population

HR is complex/multifactorial; inheritance is not Mendelian in this evidence set.

Epidemiology (recent quantitative evidence prioritized)

6–15% prevalence in non-diabetic adults ≥40 years (noted as potentially underestimated). (wang2024octaevaluateschanges pages 6-7)
In a CKD+hypertension cohort context, HR reported in >70% of non-diabetic hypertensive patients with CKD, with CKD severity linked to progression. (wang2024octaevaluateschanges pages 9-10)

Malignant hypertension prevalence (related severe phenotype)

BIHS position document reports malignant hypertension prevalence approximately 1–2/100,000 in Caucasian populations and 7.3/100,000 in African American populations. (kulkarni2023managementofhypertensive pages 2-3)

10. Diagnostics

10.1 Ophthalmoscopy / fundus photography

Traditional grading systems (e.g., KWB; Wong–Mitchell) are limited by subjectivity and interobserver variability. (marco2022aliteraturereview pages 1-2, pinto2022arterialhypertensionand pages 2-3)

10.2 Quantitative retinal vascular metrics (photo-based)

Computer-based analysis improves reproducibility and enables follow-up using standardized measures such as CRAE, CRVE, and AVR from digital photographs. (pinto2022arterialhypertensionand pages 2-3)

10.3 OCT and OCTA

Synthesis literature highlights OCT as a reproducible technique for vessel measurements and OCTA as a rapid, noninvasive method for detecting microvascular changes (vessel density/perfusion density/FAZ changes) even without overt clinical HR. (marco2022aliteraturereview pages 4-6, marco2022aliteraturereview pages 6-7)

A 2024 renal-hypertension OCTA study illustrates practical OCTA implementation: SVP/DVP density differences across segmentation approaches and potential for early detection and progression monitoring. (wang2024octaevaluateschanges pages 1-2, wang2024octaevaluateschanges pages 9-10)

10.4 Standardization and QC (key implementation issue)

OSCAR-MP (2023) provides consensus QC criteria for OCTA artifacts/quality and achieved high interrater agreement for rejecting poor-quality scans. (wicklein2023theoscarmpconsensus pages 1-2)
A 2024 systematic review/meta-analysis emphasizes massive heterogeneity of OCTA analysis approaches and calls for standardized reporting and minimum datasets (e.g., parafoveal vessel density and FAZ area). (courtie2024opticalcoherencetomography pages 34-35)

11. Outcome / Prognosis

Stroke/CVD associations (recent systematic review)

A 2024 systematic review of retinal imaging biomarkers for stroke risk reports that retinopathy presence is strongly associated with increased stroke risk; meta-analysis reports HR 2.70 (p<0.0001) for “retinopathy of any type.” (girach2024retinalimagingfor pages 7-8, girach2024retinalimagingfor pages 1-2)

BIHS notes severe retinal changes (KWB grades 3–4) reflect severe vascular permeability and poor prognosis in malignant hypertension contexts. (kulkarni2023managementofhypertensive pages 2-3)

12. Treatment

12.1 Core management

Primary therapy is systemic blood pressure reduction and vascular risk management, coordinated with primary care/internal medicine; fundus findings can guide intensity/urgency. (marco2022aliteraturereview pages 11-14)

The 2022 synthesis review states that grade III/IV retinopathy should be managed urgently and that fundus exam should be performed in suspected hypertensive emergencies to guide treatment intensity. (marco2022aliteraturereview pages 11-14)

12.2 Hypertensive crisis / malignant hypertension guidance (2023 BIHS)

BIHS emphasizes careful BP lowering to avoid hypoperfusion and ischemic complications; for uncomplicated malignant hypertension with eye changes alone, targets include: <200/120 mmHg within 24 h, <160/100 mmHg within 1 week, and <140/90 mmHg within 6–12 weeks. (kulkarni2023managementofhypertensive pages 7-8)

General emergency principle: reduce MAP no more than ~20–25% in first 6–24 hours. (kulkarni2023managementofhypertensive pages 7-8, kulkarni2023managementofhypertensive pages 5-7)

12.3 Ocular-directed adjuncts

The 2022 synthesis review notes intravitreal anti-VEGF antibodies have been reported to reduce macular edema/hemorrhages, but are not widely established as standard HR therapy. (marco2022aliteraturereview pages 11-14)

Suggested MAXO terms (ontology suggestions): antihypertensive therapy; emergency BP management; intensive monitoring/admission; fundus photography; OCT; OCTA; intravitreal anti-VEGF therapy (selected cases).

13. Prevention

Primary prevention: prevent HR by controlling hypertension and improving medication adherence/escalation. (kulkarni2023managementofhypertensive pages 3-3)
Secondary prevention: retinal imaging as a window for hypertension-mediated organ damage assessment; quantitative methods may support earlier detection than subjective grading. (pinto2022arterialhypertensionand pages 1-2, pinto2022arterialhypertensionand pages 2-3)

14. Other Species / Natural Disease

No comparative/veterinary HR evidence was identified in the retrieved set.

15. Model Organisms

No model organism resources specific to HR were identified in the retrieved set.

Recent Developments and Real-World Implementations (2023–2024 emphasis)

AI/ML applications

A 2024 IEEE Access review describes expanding use of CNN-based ML/DL methods for automated analysis of diabetic and hypertensive retinopathy, emphasizing improved accessibility and screening potential (with particular relevance to resource-limited settings). (urinatriana2024machinelearningand pages 16-17)

Clinical trial implementations (real-world grading/measurement)

RetinAIcheck (CNN) for HR grading (ClinicalTrials.gov NCT07471971; observational): trained on 30,000 specialist-relabeled fundus photographs; tested in 729 patients (1,401 eyes); grades HR by KWB classification; online resource: https://retinaai.sechenov.ru/. (NCT07471971 chunk 1)
Retinal blood flow measurement in HR (ClinicalTrials.gov NCT01753648): stage 2–3 HR vs matched controls; endpoints include total retinal blood flow, vessel diameter, velocities, and oxygen saturation using Dynamic Vessel Analyzer and Fourier-domain OCT methods. (NCT01753648 chunk 1)

Summary table (grading, mechanisms, key statistics)

Domain	Subcategory	Finding / summary	Quantitative detail	Citation
Grading/signs	Keith-Wagener-Barker grade 3	Severe hypertensive retinopathy with flame- or dot-shaped retinal hemorrhages, cotton-wool spots, hard exudates, and microaneurysms	Grade-defining lesion set	(kulkarni2023managementofhypertensive pages 2-3)
Grading/signs	Keith-Wagener-Barker grade 4	Grade 3 changes plus bilateral papilledema; reflects malignant/severe hypertensive eye involvement	Grade 4 = papilledema added to grade 3 signs	(kulkarni2023managementofhypertensive pages 2-3)
Grading/signs	Classic chronic vascular signs	Generalized/focal arteriolar narrowing, arteriovenous nicking, and copper/silver wiring are classic hypertensive retinal vascular signs	Descriptive clinical signs	(marco2022aliteraturereview pages 2-4)
Grading/signs	Other classic retinal lesions	Flame-shaped and dot-blot hemorrhages, hard exudates, cotton-wool spots, and microaneurysms are repeatedly described as classic HR findings	Descriptive clinical signs	(marco2022aliteraturereview pages 2-4)
Mechanistic phases	Vasoconstrictive phase	Acute BP elevation triggers localized vasospasm and autoregulatory arteriolar constriction; clinically seen as generalized or focal arteriolar narrowing	Acute/early phase	(marco2022aliteraturereview pages 2-4, kim2023hypertensiveretinopathy pages 2-3)
Mechanistic phases	Sclerotic phase	Chronic hypertension causes endothelial injury, intimal thickening, medial hyperplasia, and hyaline degeneration; clinically maps to AV nicking and copper/silver wiring	Chronic structural remodeling phase	(marco2022aliteraturereview pages 2-4)
Mechanistic phases	Exudative phase	Severe hypertension disrupts the blood-retina barrier and increases vascular permeability, producing hemorrhages, hard exudates, cotton-wool spots, and microaneurysms	Advanced/severe phase	(marco2022aliteraturereview pages 2-4, kim2023hypertensiveretinopathy pages 2-3)
Mechanistic phases	Ischemic tissue injury	Retinal ischemia can persist after the edematous phase and is associated with inner retinal/RNFL thinning and microcirculatory dysfunction	Persistent structural injury after ischemic lesions	(marco2022aliteraturereview pages 6-7)
Mechanistic phases	RAAS-related mechanism	In renal hypertension, RAAS activation and excess angiotensin II promote vasoconstriction/vasospasm, arterial stiffness, reduced perfusion, and lower retinal vascular density	Mechanistic link to reduced OCTA vessel density	(wang2024octaevaluateschanges pages 6-7, wang2024octaevaluateschanges pages 9-10)
Quantitative data	HR prevalence in CKD + hypertension	In non-diabetic patients with CKD and hypertension, hypertensive retinopathy was reported in over 70%	>70% prevalence	(wang2024octaevaluateschanges pages 9-10)
Quantitative data	Malignant hypertension prevalence by ancestry	Position document reports malignant hypertension prevalence around 1–2/100,000 in Caucasian populations and 7.3/100,000 in African American populations	1–2/100,000 vs 7.3/100,000	(kulkarni2023managementofhypertensive pages 2-3)
Quantitative data	Stroke risk with retinopathy (any type)	Systematic review/meta-analysis found retinopathy presence strongly associated with future stroke risk	HR 2.70, p<0.0001	(girach2024retinalimagingfor pages 7-8)
Quantitative data	Additional stroke-linked retinal features	Wider retinal venules, lower fractal dimension, increased arteriolar tortuosity, retinal emboli, and retinopathy were supported as stroke-risk markers; AV nicking/microaneurysms had weaker evidence	Qualitative strength-of-evidence summary	(girach2024retinalimagingfor pages 1-2)

Table: This table condenses the most useful disease-characteristic facts for hypertensive retinopathy: classic grading/signs, mechanism-to-phenotype mapping, and recent quantitative prognostic and epidemiologic data. It is useful as a quick reference for building a structured knowledge-base entry.

Direct abstract-supported statements (quotes)

“Retinal imaging allows non-invasive assessment of the microvasculature.” (2024 stroke-risk systematic review) (girach2024retinalimagingfor pages 7-8)
“To date, there are no validated consensus criteria for quality control (QC) of OCTA.” (2023 OSCAR-MP paper) (wicklein2023theoscarmpconsensus pages 1-2)
“Patients with hypertensive emergencies, malignant hypertension and acute severe hypertension are managed heterogeneously in clinical practice.” (2023 BIHS position paper) (kulkarni2023managementofhypertensive pages 2-3)

Gaps / limitations of this run

ICD/MeSH/MONDO/OMIM/Orphanet IDs were not available in the retrieved evidence texts; identifiers are therefore not asserted.
Image retrieval: attempts to retrieve and cite a cropped figure/table failed due to tool access errors; thus, no image citations are included.
Genetic/omics: no HR-specific GWAS/omics/epigenetic profiling evidence was identified in the retrieved set.

Key URLs and publication dates (subset of cited sources)

Kulkarni et al. Journal of Human Hypertension (Nov 2023): https://doi.org/10.1038/s41371-022-00776-9 (kulkarni2023managementofhypertensive pages 2-3)
Wang et al. Scientific Reports (Nov 2024): https://doi.org/10.1038/s41598-024-68690-3 (wang2024octaevaluateschanges pages 9-10)
Girach et al. Journal of Neurology (Mar 2024): https://doi.org/10.1007/s00415-023-12171-6 (girach2024retinalimagingfor pages 7-8)
Wicklein et al. Neurol Neuroimmunol Neuroinflamm (Nov 2023): https://doi.org/10.1212/nxi.0000000000200169 (wicklein2023theoscarmpconsensus pages 1-2)
Courtie et al. Scientific Reports (Apr 2024): https://doi.org/10.1038/s41598-024-54306-3 (courtie2024opticalcoherencetomography pages 34-35)
Del Pinto et al. Nutrients (May 2022): https://doi.org/10.3390/nu14112200 (pinto2022arterialhypertensionand pages 1-2)
Di Marco et al. Eur Rev Med Pharmacol Sci (Sep 2022): https://doi.org/10.26355/eurrev_202209_29742 (marco2022aliteraturereview pages 2-4)
ClinicalTrials.gov NCT07471971 (resource): https://retinaai.sechenov.ru/ (NCT07471971 chunk 1)

References

(marco2022aliteraturereview pages 2-4): E. Di Marco, F. Aiello, M. Lombardo, M. Di Marino, F. Missiroli, R. Mancino, F. Ricci, C. Nucci, A. Noce, N. Di Daniele, and M. Cesareo. A literature review of hypertensive retinopathy: systemic correlations and new technologies. European review for medical and pharmacological sciences, 26 18:6424-6443, Sep 2022. URL: https://doi.org/10.26355/eurrev_202209_29742, doi:10.26355/eurrev_202209_29742. This article has 67 citations.
(kulkarni2023managementofhypertensive pages 2-3): Spoorthy Kulkarni, Mark Glover, Vikas Kapil, S. M. L. Abrams, Sarah Partridge, Terry McCormack, Peter Sever, Christian Delles, and Ian B. Wilkinson. Management of hypertensive crisis: british and irish hypertension society position document. Journal of Human Hypertension, 37:863-879, Nov 2023. URL: https://doi.org/10.1038/s41371-022-00776-9, doi:10.1038/s41371-022-00776-9. This article has 119 citations and is from a peer-reviewed journal.
(kim2023hypertensiveretinopathy pages 1-2): Ophthalmologica and Sohan Singh. Hypertensive retinopathy. Definitions, Jan 2020. URL: https://doi.org/10.1159/000309997, doi:10.1159/000309997. This article has 383 citations.
(marco2022aliteraturereview pages 4-6): E. Di Marco, F. Aiello, M. Lombardo, M. Di Marino, F. Missiroli, R. Mancino, F. Ricci, C. Nucci, A. Noce, N. Di Daniele, and M. Cesareo. A literature review of hypertensive retinopathy: systemic correlations and new technologies. European review for medical and pharmacological sciences, 26 18:6424-6443, Sep 2022. URL: https://doi.org/10.26355/eurrev_202209_29742, doi:10.26355/eurrev_202209_29742. This article has 67 citations.
(kim2023hypertensiveretinopathy pages 2-3): Ophthalmologica and Sohan Singh. Hypertensive retinopathy. Definitions, Jan 2020. URL: https://doi.org/10.1159/000309997, doi:10.1159/000309997. This article has 383 citations.
(wang2024octaevaluateschanges pages 6-7): Le Wang, Jun-Yi Wang, Cheng Chen, Min Kang, San-Hua Xu, Hong Wei, Qian Ling, Liang-Qi He, Jie Zou, Xu Chen, Ping Ying, Hui Huang, and Yi Shao. Octa evaluates changes in retinal microvasculature in renal hypertension patients. Scientific Reports, Nov 2024. URL: https://doi.org/10.1038/s41598-024-68690-3, doi:10.1038/s41598-024-68690-3. This article has 11 citations and is from a peer-reviewed journal.
(wang2024octaevaluateschanges pages 9-10): Le Wang, Jun-Yi Wang, Cheng Chen, Min Kang, San-Hua Xu, Hong Wei, Qian Ling, Liang-Qi He, Jie Zou, Xu Chen, Ping Ying, Hui Huang, and Yi Shao. Octa evaluates changes in retinal microvasculature in renal hypertension patients. Scientific Reports, Nov 2024. URL: https://doi.org/10.1038/s41598-024-68690-3, doi:10.1038/s41598-024-68690-3. This article has 11 citations and is from a peer-reviewed journal.
(marco2022aliteraturereview pages 1-2): E. Di Marco, F. Aiello, M. Lombardo, M. Di Marino, F. Missiroli, R. Mancino, F. Ricci, C. Nucci, A. Noce, N. Di Daniele, and M. Cesareo. A literature review of hypertensive retinopathy: systemic correlations and new technologies. European review for medical and pharmacological sciences, 26 18:6424-6443, Sep 2022. URL: https://doi.org/10.26355/eurrev_202209_29742, doi:10.26355/eurrev_202209_29742. This article has 67 citations.
(marco2022aliteraturereview pages 6-7): E. Di Marco, F. Aiello, M. Lombardo, M. Di Marino, F. Missiroli, R. Mancino, F. Ricci, C. Nucci, A. Noce, N. Di Daniele, and M. Cesareo. A literature review of hypertensive retinopathy: systemic correlations and new technologies. European review for medical and pharmacological sciences, 26 18:6424-6443, Sep 2022. URL: https://doi.org/10.26355/eurrev_202209_29742, doi:10.26355/eurrev_202209_29742. This article has 67 citations.
(pinto2022arterialhypertensionand pages 2-3): Rita Del Pinto, Giuseppe Mulè, Maria Vadalà, Caterina Carollo, Santina Cottone, Claudia Agabiti Rosei, Carolina De Ciuceis, Damiano Rizzoni, Claudio Ferri, and Maria Lorenza Muiesan. Arterial hypertension and the hidden disease of the eye: diagnostic tools and therapeutic strategies. Nutrients, 14:2200, May 2022. URL: https://doi.org/10.3390/nu14112200, doi:10.3390/nu14112200. This article has 31 citations.
(wang2024octaevaluateschanges pages 1-2): Le Wang, Jun-Yi Wang, Cheng Chen, Min Kang, San-Hua Xu, Hong Wei, Qian Ling, Liang-Qi He, Jie Zou, Xu Chen, Ping Ying, Hui Huang, and Yi Shao. Octa evaluates changes in retinal microvasculature in renal hypertension patients. Scientific Reports, Nov 2024. URL: https://doi.org/10.1038/s41598-024-68690-3, doi:10.1038/s41598-024-68690-3. This article has 11 citations and is from a peer-reviewed journal.
(wicklein2023theoscarmpconsensus pages 1-2): Rebecca Wicklein, Charmaine Yam, Christina Noll, Lilian Aly, Nicolas Banze, Eva Feodora Romahn, Elisabeth Wolf, Bernhard Hemmer, Frederike C. Oertel, Hanna Zimmermann, Philipp Albrecht, Marius Ringelstein, Carmen Baumann, Nikolaus Feucht, Josef Penkava, Joachim Havla, Jonathan A. Gernert, Christian Mardin, Eleni S. Vasileiou, Anneke Van Der Walt, Omar Al-Louzi, Sergio Cabello, Angela Vidal-Jordana, Julia Krämer, Heinz Wiendl, Jana Lizrova Preiningerova, Olga Ciccarelli, Elena Garcia-Martin, Veronika Kana, Peter A. Calabresi, Friedemann Paul, Shiv Saidha, Axel Petzold, Ahmed T. Toosy, and Benjamin Knier. The oscar-mp consensus criteria for quality assessment of retinal optical coherence tomography angiography. Neurology Neuroimmunology & Neuroinflammation, Nov 2023. URL: https://doi.org/10.1212/nxi.0000000000200169, doi:10.1212/nxi.0000000000200169. This article has 35 citations.
(courtie2024opticalcoherencetomography pages 34-35): Ella Courtie, James Robert Moore Kirkpatrick, Matthew Taylor, Livia Faes, Xiaoxuan Liu, Ann Logan, Tonny Veenith, Alastair K. Denniston, and Richard J. Blanch. Optical coherence tomography angiography analysis methods: a systematic review and meta-analysis. Scientific Reports, Apr 2024. URL: https://doi.org/10.1038/s41598-024-54306-3, doi:10.1038/s41598-024-54306-3. This article has 18 citations and is from a peer-reviewed journal.
(girach2024retinalimagingfor pages 7-8): Zain Girach, Arni Sarian, Cynthia Maldonado-García, Nishant Ravikumar, Panagiotis I. Sergouniotis, Peter M. Rothwell, Alejandro F. Frangi, and Thomas H. Julian. Retinal imaging for the assessment of stroke risk: a systematic review. Journal of neurology, 271:2285-2297, Mar 2024. URL: https://doi.org/10.1007/s00415-023-12171-6, doi:10.1007/s00415-023-12171-6. This article has 40 citations and is from a domain leading peer-reviewed journal.
(girach2024retinalimagingfor pages 1-2): Zain Girach, Arni Sarian, Cynthia Maldonado-García, Nishant Ravikumar, Panagiotis I. Sergouniotis, Peter M. Rothwell, Alejandro F. Frangi, and Thomas H. Julian. Retinal imaging for the assessment of stroke risk: a systematic review. Journal of neurology, 271:2285-2297, Mar 2024. URL: https://doi.org/10.1007/s00415-023-12171-6, doi:10.1007/s00415-023-12171-6. This article has 40 citations and is from a domain leading peer-reviewed journal.
(marco2022aliteraturereview pages 11-14): E. Di Marco, F. Aiello, M. Lombardo, M. Di Marino, F. Missiroli, R. Mancino, F. Ricci, C. Nucci, A. Noce, N. Di Daniele, and M. Cesareo. A literature review of hypertensive retinopathy: systemic correlations and new technologies. European review for medical and pharmacological sciences, 26 18:6424-6443, Sep 2022. URL: https://doi.org/10.26355/eurrev_202209_29742, doi:10.26355/eurrev_202209_29742. This article has 67 citations.
(kulkarni2023managementofhypertensive pages 7-8): Spoorthy Kulkarni, Mark Glover, Vikas Kapil, S. M. L. Abrams, Sarah Partridge, Terry McCormack, Peter Sever, Christian Delles, and Ian B. Wilkinson. Management of hypertensive crisis: british and irish hypertension society position document. Journal of Human Hypertension, 37:863-879, Nov 2023. URL: https://doi.org/10.1038/s41371-022-00776-9, doi:10.1038/s41371-022-00776-9. This article has 119 citations and is from a peer-reviewed journal.
(kulkarni2023managementofhypertensive pages 5-7): Spoorthy Kulkarni, Mark Glover, Vikas Kapil, S. M. L. Abrams, Sarah Partridge, Terry McCormack, Peter Sever, Christian Delles, and Ian B. Wilkinson. Management of hypertensive crisis: british and irish hypertension society position document. Journal of Human Hypertension, 37:863-879, Nov 2023. URL: https://doi.org/10.1038/s41371-022-00776-9, doi:10.1038/s41371-022-00776-9. This article has 119 citations and is from a peer-reviewed journal.
(kulkarni2023managementofhypertensive pages 3-3): Spoorthy Kulkarni, Mark Glover, Vikas Kapil, S. M. L. Abrams, Sarah Partridge, Terry McCormack, Peter Sever, Christian Delles, and Ian B. Wilkinson. Management of hypertensive crisis: british and irish hypertension society position document. Journal of Human Hypertension, 37:863-879, Nov 2023. URL: https://doi.org/10.1038/s41371-022-00776-9, doi:10.1038/s41371-022-00776-9. This article has 119 citations and is from a peer-reviewed journal.
(pinto2022arterialhypertensionand pages 1-2): Rita Del Pinto, Giuseppe Mulè, Maria Vadalà, Caterina Carollo, Santina Cottone, Claudia Agabiti Rosei, Carolina De Ciuceis, Damiano Rizzoni, Claudio Ferri, and Maria Lorenza Muiesan. Arterial hypertension and the hidden disease of the eye: diagnostic tools and therapeutic strategies. Nutrients, 14:2200, May 2022. URL: https://doi.org/10.3390/nu14112200, doi:10.3390/nu14112200. This article has 31 citations.
(urinatriana2024machinelearningand pages 16-17): Miguel Alberto Urina-Triana, Marlon Alberto Piñeres-Melo, Mirary Mantilla-Morrón, Shariq Butt-Aziz, Luisa Galeano-Muñoz, Sumera Naz, and Paola Patricia Ariza-Colpas. Machine learning and ai approaches for analyzing diabetic and hypertensive retinopathy in ocular images: a literature review. IEEE Access, 12:54590-54607, Jan 2024. URL: https://doi.org/10.1109/access.2024.3378277, doi:10.1109/access.2024.3378277. This article has 31 citations and is from a peer-reviewed journal.
(NCT07471971 chunk 1): Assessment of Hypertensive Retinopathy Using Convolutional Neural Network "RetinAIcheck". I.M. Sechenov First Moscow State Medical University. 2021. ClinicalTrials.gov Identifier: NCT07471971
(NCT01753648 chunk 1): Gerhard Garhofer. Non-invasive Measurement of Retinal Blood Flow Based on Vessel Analysis and Fourier Domain Optical Coherence Tomography in Patients With Hypertensive Retinopathy. Medical University of Vienna. 2015. ClinicalTrials.gov Identifier: NCT01753648

Artifacts

Edison artifact artifact-00

Ask OpenScientist

OpenScientist Report

Pathophysiology

Pathograph

Phenotypes

Medical Actions

Environmental Factors

Diagnosis

Prevalence

Source YAML

References & Deep Research

References

Deep Research

1. Disease Information

1.1 Concise overview (current understanding)

1.2 Key identifiers (ontology/terminology)

1.3 Synonyms and alternative names

1.4 Evidence source type

2. Etiology

2.1 Causal factors

2.2 Risk factors (representative)

2.3 Protective factors

2.4 Gene–environment interactions

3. Phenotypes

3.1 Classic fundus signs

3.2 Retinal layers/structural phenotypes (OCT/OCTA era)

3.3 Distinguishing related entities (malignant hypertension)

Suggested HPO term mappings (ontology suggestions; not evidence-asserted)

4. Genetic/Molecular Information

4.1 Causal genes and pathogenic variants

4.2 Molecular mediators and pathways

5. Environmental Information

6. Mechanism / Pathophysiology (causal chain)

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

Epidemiology (recent quantitative evidence prioritized)

Malignant hypertension prevalence (related severe phenotype)

10. Diagnostics

10.1 Ophthalmoscopy / fundus photography

10.2 Quantitative retinal vascular metrics (photo-based)

10.3 OCT and OCTA

10.4 Standardization and QC (key implementation issue)

11. Outcome / Prognosis

Stroke/CVD associations (recent systematic review)

12. Treatment

12.1 Core management

12.2 Hypertensive crisis / malignant hypertension guidance (2023 BIHS)

12.3 Ocular-directed adjuncts

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Recent Developments and Real-World Implementations (2023–2024 emphasis)

AI/ML applications

Clinical trial implementations (real-world grading/measurement)

Summary table (grading, mechanisms, key statistics)

Direct abstract-supported statements (quotes)

Gaps / limitations of this run

Key URLs and publication dates (subset of cited sources)

Artifacts